Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Ketone body β-hydroxybutyrate is an autophagy-dependent vasodilator
Cameron G. McCarthy, … , Camilla F. Wenceslau, Bina Joe
Cameron G. McCarthy, … , Camilla F. Wenceslau, Bina Joe
Published September 9, 2021
Citation Information: JCI Insight. 2021;6(20):e149037. https://doi.org/10.1172/jci.insight.149037.
View: Text | PDF
Research Article Vascular biology

Ketone body β-hydroxybutyrate is an autophagy-dependent vasodilator

  • Text
  • PDF
Abstract

Autophagy has long been associated with longevity, and it is well established that autophagy reverts and prevents vascular deterioration associated with aging and cardiovascular diseases. Currently, our understanding of how autophagy benefits the vasculature is centered on the premise that reduced autophagy leads to the accumulation of cellular debris, resulting in inflammation and oxidative stress, which are then reversed by reconstitution or upregulation of autophagic activity. Evolutionarily, autophagy also functions to mobilize endogenous nutrients in response to starvation. Therefore, we hypothesized that the biosynthesis of the most physiologically abundant ketone body, β-hydroxybutyrate (βHB), would be autophagy dependent and exert vasodilatory effects via its canonical receptor, Gpr109a. To the best of our knowledge, we have revealed for the first time that the biosynthesis of βHB can be impaired by preventing autophagy. Subsequently, βHB caused potent vasodilation via potassium channels but not Gpr109a. Finally, we observed that chronic consumption of a high-salt diet negatively regulates both βHB biosynthesis and hepatic autophagy and that reconstitution of βHB bioavailability prevents high-salt diet–induced endothelial dysfunction. In summary, this work offers an alternative mechanism to the antiinflammatory and antioxidative stress hypothesis of autophagy-dependent vasculoprotection. Furthermore, it reveals a direct mechanism by which ketogenic interventions (e.g., intermittent fasting) improve vascular health.

Authors

Cameron G. McCarthy, Saroj Chakraborty, Gagandeep Singh, Beng San Yeoh, Zachary J. Schreckenberger, Avinash Singh, Blair Mell, Nicole R. Bearss, Tao Yang, Xi Cheng, Matam Vijay-Kumar, Camilla F. Wenceslau, Bina Joe

×

Figure 5

Reconstitution of β-hydroxybutyrate bioavailability prevents high-salt diet–induced endothelial dysfunction in Dahl S and Dahl R rats.

Options: View larger image (or click on image) Download as PowerPoint
Reconstitution of β-hydroxybutyrate bioavailability prevents high-salt d...
Acetylcholine (ACh) concentration-response curves in mesenteric resistance arteries from low-salt diet–fed (LS-fed) Dahl S rats (A), high-salt diet–fed (HS-fed) Dahl S rats (B), and HS-fed animals Dahl S rats with 1,3-butanediol (1,3-BD; 20% v/v) (C) after incubation with Nω-Nitro-L-arginine methyl ester (L-NAME, 100 μmol/L). ACh concentration-response curves in L-NAME–incubated arteries from HS-fed Dahl S rats that were either coincubated with tetraethylammonium (TEA, 10 mmol/L) (D) or contracted in response to potassium chloride (KCl, 120 mmol/L), as opposed to phenylephrine (10 μmol/L) (E). ACh concentration-response curves in L-NAME–incubated arteries from HS-fed Dahl S rats that were also coincubated with UCL 1684 (100 nmol/L) and TRAM-34 (10 μmol/L) combined, iberiotoxin (100 nmol/L), barium chloride (100 μmol/L), or glybenclamide (1 μmol/L) (F). ACh concentration-response curves in arteries from LS-fed Dahl R rats (G), HS-fed Dahl R rats (H), and HS-fed Dahl R rats treated with 1,3-BD (I) after incubation with indomethacin (10 μmol/L). Mean ± SEM. n = 4–11. Two-way ANOVA: *P < 0.05 (A–E); 1-way ANOVA: **P < 0.01 (F); nonlinear regression (logEC50): *P < 0.05 (H).

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts